Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-22-036240

Options or other derivatives

  • Chief Technology Officer acquired 625,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Liu Hui · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-20 Grant or award : show line 1 in the form Stock Option (right to Buy) +625,000 625,000 D
Loading xslF345X03/ownership.xml…